183 related articles for article (PubMed ID: 6822421)
1. Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule.
Brown EJ; Joiner KA; Cole RM; Berger M
Infect Immun; 1983 Jan; 39(1):403-9. PubMed ID: 6822421
[TBL] [Abstract][Full Text] [Related]
2. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
Holzer TJ; Edwards KM; Gewurz H; Mold C
J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
[TBL] [Abstract][Full Text] [Related]
3. The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream.
Brown EJ; Hosea SW; Frank MM
Rev Infect Dis; 1983; 5 Suppl 4():S797-805. PubMed ID: 6356294
[TBL] [Abstract][Full Text] [Related]
4. Classical complement pathway activation by antipneumococcal antibodies leads to covalent binding of C3b to antibody molecules.
Brown EJ; Berger M; Joiner KA; Frank MM
Infect Immun; 1983 Nov; 42(2):594-8. PubMed ID: 6642644
[TBL] [Abstract][Full Text] [Related]
5. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
[TBL] [Abstract][Full Text] [Related]
6. Defective binding of the third component of complement (C3) to Streptococcus pneumoniae in multiple myeloma.
Cheson BD; Walker HS; Heath ME; Gobel RJ; Janatova J
Blood; 1984 Apr; 63(4):949-57. PubMed ID: 6231069
[TBL] [Abstract][Full Text] [Related]
7. Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factor H binding and opsonization with C3b/iC3b.
Hyams C; Trzcinski K; Camberlein E; Weinberger DM; Chimalapati S; Noursadeghi M; Lipsitch M; Brown JS
Infect Immun; 2013 Jan; 81(1):354-63. PubMed ID: 23147038
[TBL] [Abstract][Full Text] [Related]
8. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production.
Hostetter MK
J Infect Dis; 1986 Apr; 153(4):682-93. PubMed ID: 3950449
[TBL] [Abstract][Full Text] [Related]
9. Deposition and degradation of C3 on type III group B streptococci.
Campbell JR; Baker CJ; Edwards MS
Infect Immun; 1991 Jun; 59(6):1978-83. PubMed ID: 2037359
[TBL] [Abstract][Full Text] [Related]
10. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae.
Tu AH; Fulgham RL; McCrory MA; Briles DE; Szalai AJ
Infect Immun; 1999 Sep; 67(9):4720-4. PubMed ID: 10456922
[TBL] [Abstract][Full Text] [Related]
12. Effect of a C1s Inhibitor on the Efficacy of Anti-Capsular Antibodies against
Lewis LA; Panicker S; DeOliveira RB; Parry GC; Ram S
Immunohorizons; 2019 Nov; 3(11):519-530. PubMed ID: 31690560
[TBL] [Abstract][Full Text] [Related]
13. Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.
Yuste J; Sen A; Truedsson L; Jönsson G; Tay LS; Hyams C; Baxendale HE; Goldblatt F; Botto M; Brown JS
Infect Immun; 2008 Aug; 76(8):3761-70. PubMed ID: 18541650
[TBL] [Abstract][Full Text] [Related]
14. Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface.
Ren B; Szalai AJ; Hollingshead SK; Briles DE
Infect Immun; 2004 Jan; 72(1):114-22. PubMed ID: 14688088
[TBL] [Abstract][Full Text] [Related]
15. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms.
Hyams C; Camberlein E; Cohen JM; Bax K; Brown JS
Infect Immun; 2010 Feb; 78(2):704-15. PubMed ID: 19948837
[TBL] [Abstract][Full Text] [Related]
16. Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis.
Wilkinson BJ; Sisson SP; Kim Y; Peterson PK
Infect Immun; 1979 Dec; 26(3):1159-63. PubMed ID: 393630
[TBL] [Abstract][Full Text] [Related]
17. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.
Winkelstein JA; Abramovitz AS; Tomasz A
J Immunol; 1980 May; 124(5):2502-6. PubMed ID: 7365262
[No Abstract] [Full Text] [Related]
18. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
Mold C; Kingzette M; Gewurz H
J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
[TBL] [Abstract][Full Text] [Related]
19. Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B.
Melin M; Jarva H; Siira L; Meri S; Käyhty H; Väkeväinen M
Infect Immun; 2009 Feb; 77(2):676-84. PubMed ID: 19047408
[TBL] [Abstract][Full Text] [Related]
20. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
